Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
about
HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, BrazilDevelopment of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV.Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.Seven Years Trends in Prevalence of Transfusion-Transmissible Viral Infections in Yazd blood Transfusion OrganizationContribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil.Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century.A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.Contrasting HCV and HIV seroepidemiology in 11 years of blood donors screening in Brazil.Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany.Changes in the prevalence, incidence and residual risk for HIV and hepatitis C virus in Southern Brazilian blood donors since the implementation of NAT screening.Health-related quality of life among blood donors with hepatitis B and hepatitis C: longitudinal study before and after diagnosis.Positive serology for viral hepatitis and donor self-exclusion in Southern Brazil.The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey
P2860
Q28538943-19C885FF-5C3B-4DEE-B72E-BA90ABBF9F87Q30491951-BCC6A258-1FC2-4BD8-AFE7-0EBEA553EAD9Q37296858-358F1189-1204-449C-A4A0-85348E916BEEQ37579277-75B5FA82-6049-4E78-A90C-991A3387F625Q37734062-5FBDB1BD-2C02-4051-B342-3D9CA14348CCQ38675031-E8A0D2D1-6A2E-42F3-A426-83444AAA4012Q39137413-231C130A-7A2E-4D2E-8A97-0CDB27E100ADQ40169707-E5A0E547-B3EE-4A24-9BB2-2009C54901E6Q40194957-DABE826D-D7F7-4C2C-8477-352458141395Q41692988-9A55F524-9982-4B5B-BA13-E074FAB8C31EQ41736265-9804E348-F5CB-4201-9642-C9292C68FF5BQ41887081-EEE56E37-1D2C-4A88-BA79-1D139AA6231DQ42273881-7EBB8375-86E5-48B1-A826-8D1E45175F7FQ42993391-DC215EB8-CF87-401E-9AC5-EA5BEBBFCBBEQ58776091-8BA04D92-BD11-47BF-A33A-2AA836BC9740
P2860
Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prevalence of serologic marker ...... smission of hepatitis C virus.
@ast
Prevalence of serologic marker ...... smission of hepatitis C virus.
@en
type
label
Prevalence of serologic marker ...... smission of hepatitis C virus.
@ast
Prevalence of serologic marker ...... smission of hepatitis C virus.
@en
prefLabel
Prevalence of serologic marker ...... smission of hepatitis C virus.
@ast
Prevalence of serologic marker ...... smission of hepatitis C virus.
@en
P2093
P2860
P1433
P1476
Prevalence of serologic marker ...... smission of hepatitis C virus.
@en
P2093
Alfredo Mendrone-Junior
Cesar de Almeida-Neto
David J Wright
Edward L Murphy
Ester Cerdeira Sabino
Fernando Valadares Basques
João Eduardo Ferreira
NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component
Nanci Alves Salles
P2860
P304
P356
10.1111/J.1537-2995.2012.03840.X
P577
2012-08-06T00:00:00Z